Wedelolactone Inhibits Breast Cancer-Induced Osteoclastogenesis by Decreasing Akt/mTOR Signaling
International Journal of Oncology - Greece
doi 10.3892/ijo.2014.2769
Full Text
Open PDFAbstract
Available in full text
Date
November 21, 2014
Authors
Publisher
Spandidos Publications